Roza M. Esayan

Roza M. Esayan

Auto-generated profile, based on publicly available information

Roza M. Esayan

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2017 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
IDIvan I. Dedov
Ivan I. Dedov
MSMarina Shestakova
Marina Shestakova
AMAleksandr Y. Mayorov
Aleksandr Y. Mayorov
OVOlga K. Vikulova
Olga K. Vikulova
GGGagik R. Galstyan
Gagik R. Galstyan
СЮСухарева Ольга Юрьевна
Сухарева Ольга Юрьевна
Dear Colleagues! We are glad to present the8th Editionof Standards of Diabetes Care. These evidence-based guidelines were designed to standardize and facilitate diabetes care in all regions of the Russian Federation. The Standards are updated on the regular basis to incorporate new data and relevant recommendations from national and international clinical societies, including World Health Organization Guidelines (WHO, 2011, 2013), International Diabetes Federation (IDF, 2011, 2012, 2013), American Diabetes Association (ADA, 2012, 2017), American Association of Clinical Endocrinologists (AACE, 2017), International Society for Pediatric and Adolescent Diabetes (ISPAD, 2014) and Russian Association of Endocrinologists (RAE, 2011, 2012, 2015). Current edition of the Standards also integrates results of completed randomized clinical trials (ADVANCE, ACCORD, VADT, UKPDS, SAVOR, TECOS, LEADER, EMPA-REG OUTCOME, etc.), as well as findings from the national studies of diabetes mellitus (DM), conducted in close partnership with a number of Russian hospitals. Latest data indicates that prevalence of DM in the world increased during the last decade more than two-fold, reaching some 415 million patients by the end of 2015. According to the current estimation by the International Diabetes Federation, 642 million patients will be suffering from DM by 2040. These observations resulted in the UN Resolution on Diabetes 61/225 passed on 20.12.2006, and in 2011 - UN Political Declaration, addressed to national health systems, calling for the establishment of multidisciplinary strategy in the prevention and control of non-communicable diseases, where special attention is drawn to the problem of diabetes as one of the leading causes of disability and mortality. Like many other countries, Russian Federation experiences a sharp rise in the prevalence of DM. According to Russian Federal Diabetes Register, there are at least 4.35 million patients with DM in this country by the end of 2016 (3% of population) with 92% (4 million) Type 2 DM, 6% (255 th) Type 1 DM and 2% (75 th) other types of DM. However, these results underestimates real quantity of patients, because they consider only registered cases. Results of Russian epidemiological study (NATION) confirmed that only 50% of Type 2 DM are diagnosed. So real prevalence of patients with DM in Russia is no less than 8-9 million patients (about 6% of population). This is a great long-term problem, because a lot of patients are not diagnosed, so they dont receive any treatment ant have high risk of vascular complications. Severe consequences of the global pandemics of DM include its vascular complications: nephropathy, retinopathy, coronary, cerebral, coronary and peripheral vascular disease. These conditions are responsible for the majority of cases of diabetes-related disability and death. Current edition of the Standards emphasizes the patient-oriented approach in making decisions on therapeutic goals, such as levels of glycaemia and blood pressure. It also features updated guidelines on the management of Type 2 DM and its vascular complications, added information about bariatric surgery as a method of treatment of DM with morbide obesity. This text represents a consensus by the absolute majority of national experts, achieved through a number of fruitful discussions held at national meetings and forums. These guidelines are intended for endocrinologists and diabetologists, primary care physicians, cardiologists and other medical professionals involved in prevention and treatment of DM. On behalf of the Working Group

22 October 2021 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
GMG. A. Melnichenko
G. A. Melnichenko
LAL. V. Adamyan
L. V. Adamyan
ETEkaterina Troshina
Ekaterina Troshina
NMN. V. Molashenko
N. V. Molashenko
LSL. V. Suturina
L. V. Suturina
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive diseases characterized by a defect in one of the enzymes or transport proteins involved in the cortisol synthesis in the adrenal cortex. The most common form of CAH, which occurs in more than 90% of cases, is a 21-hydroxylase enzyme deficiency. The latter is subdivided into nonclassical and classic (salt-losing and virilizing) forms. The prevalence of classic forms of 21-hydroxylase deficiency ranges from 1: 14,000 to 1:18,000 live births worldwide. According to the data of neonatal screening in the Russian Federation, the prevalence of the disease in some regions ranges from 1: 5000 to 1: 12000, in the country as a whole - 1: 9638 live newborns. The non-classical form of CAH occurs more often - from 1: 500 to 1: 1000 among the general population. In second place is the hypertensive form of CAH - a deficiency of 11β-hydroxylase, which, according to the literature, occurs in about 1 per 100,000 newborns. These clinical guidelines were compiled by a professional community of narrow specialists, approved by the expert council of the Ministry of Health of the Russian Federation, and updated the previous version published in 2016. The clinical guidelines are based on systematic reviews, meta-analyses and original articles, and scientific work on this issue in the Russian Federation and other countries. The purpose of this document is to provide clinicians with the most up-to-date, evidence-based guidelines for the CAH diagnosis and treatment

15 December 2021 in Journal of Clinical Practice
Verified
Journal Article
Open access
PDF file
LKLyubov Valentinovna Krechetova
Lyubov Valentinovna Krechetova
DNDmitry NECHIPURENKO
Dmitry NECHIPURENKO
MSMargarita A. Shpilyuk
Margarita A. Shpilyuk
OBOlga Beznoshchenco
Olga Beznoshchenco
EBEvgeniya A. Beresneva
Evgeniya A. Beresneva
РГРумянцев Александр Григорьевич
Румянцев Александр Григорьевич
Background: At the present moment, an urgent and unresolved problem is the search for a method to diagnose disorders of the hemostasis system in patients with the new coronavirus infection. The integral tests, in particular, the thrombodynamics test, will presumably make it possible to monitor changes in blood clotting, and predict the course of the disease in patients with COVID-19. Aims: To comparatively assess the plasma hemostasis parameters and results of the thrombodynamics test in patients with COVID-19 viral infection of different severity. Methods: The study included 96 patients with a confirmed diagnosis of COVID-19, admitted to a hospital for infectious diseases on the base of the V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology in the period from April 23, 2020, to June 20, 2020, and discharged at the end of treatment. SARS-CoV-2 was identified by PCR. The patients were stratified by the severity into 3 groups: mild course (n=25), moderate course (n=54), severe course (n=17). The diagnostics and treatment of patients were carried out in accordance with the Temporary Methodological Recommendations of the Ministry of Health of the Russian Federation for the prevention, diagnosis and treatment of the new coronavirus infection, versions 5, 6, 7. In the course of the treatment, the patients were assessed for APTT, prothrombin %, prothrombin time (PT) and thrombin time, fibrinogen, D-dimer, platelet count, and the thrombodynamic test parameters (V/Vi/Vst, Tlag, Cs, D). Results: Significant differences were observed in the thrombin time, D-dimer, platelet count, and the thrombodynamic parameters of V/Vst, Cs, and D taken before admission and a week after admission. We found a relationship between the parameters of hemostasis (fibrinogen concentration, PT, prothrombin %, APTT, Tlag, D) and the duration of hospital stay. There was a positive relationship between the content of fibrinogen and D (r=0.6307, p 0.0001) and a strong positive relationship between PT and Tlag (r=0.7499, p 0.0001). Conclusions: The thrombodynamics test can be recommended as a potential tool for a personalized approach to monitoring the hemostasis system and treating patients with COVID-19.

26 March 2025 in Bulletin of Reproductive Health
Verified
Journal Article
Open access
PDF file
EAE. N. Andreeva
E. N. Andreeva
NAN. Yu. Arbatskaya
N. Yu. Arbatskaya
OAO. N. Arzhanova
O. N. Arzhanova
NBN. V. Bashmakova
N. V. Bashmakova
NBN. V. Borovik
N. V. Borovik
НАН. Ю. Арбатская
Н. Ю. Арбатская
The present article contains the newest ant the most actual version of clinical recommendations “Gestational diabetes mellitus” of the Russian Ministry of Health. This document has been confirmed for the period from 2024 until 2026 year. Gestational diabetes mellitus is widely known as onset of hyperglycaemia during pregnancy that does not responds to criteria of manifesting diabetes mellitus (DM). The time of next revision is 2026 year or earlier if new evidentiary material appear. The present version of clinical recommendation has been created due to collaboration between Russian Association of Endocrinologists and Russian Society of Obstetricians and Gynecologists. The document is finally approved by scientific and practical Council of the Russian Ministry of Health.

17 January 2012 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
EDE. A. Dubova
E. A. Dubova
KPKonstantin Pavlov
Konstantin Pavlov
RER. M. Esayan
R. M. Esayan
EDE. I. Degtyareva
E. I. Degtyareva
MSMarina Shestakova
Marina Shestakova
GSG. T. Sukhikh
G. T. Sukhikh

27 August 2016 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
GGGardanova Zh.R. Gardanova
Gardanova Zh.R. Gardanova
AAAnisimova K.A. Anisimova
Anisimova K.A. Anisimova
VVVasilyeva A.V. Vasilyeva
Vasilyeva A.V. Vasilyeva
EEEsayan R.M. Esayan
Esayan R.M. Esayan
TTTetruashvili N.K. Tetruashvili
Tetruashvili N.K. Tetruashvili
SSSokov D.G. Sokov
Sokov D.G. Sokov